Decision Resources, one of the world's leading research and advisory firms focusing on pharmaceutical and healthcare issues, finds that 52.3 percent of new patients diagnosed with bipolar disorder are prescribed antidepressants province.
The new report, entitled "Algorithms for the treatment of bipolar disorder is of the opinion that such a high preponderance of first-line use of antidepressants has made primary care prescribing doctor. Surveyed primary care physicians indicate a selective inhibitor of serotonin reuptake (SSRIs), Including Forest laboratories "Lexapro, as first-line treatment of patients with bipolar I disorder with major depression (51 percent of physicians), bipolar disorder II with severe depression, with hypo mania (52 per cent of doctors) and bipolar disorder II with severe depression, with hypo mania (46 percent of physicians).
"The number of doctors of primary health care, diagnosis and treatment of bipolar patients has been in recent years, but still treated differently structure interviewed psychiatrists," said Madhuri BORDE, Ph.D., analyst Decision Resources. "Nearly half of patients who receive SSRIs forefront of these drugs as monotherapy, despite the recommendations of management for patients with bipolar depression antimanic province."
The report also notes that GSK Lamictal is the largest agent in the first, second and third-line therapy cumulative 18 per cent, 13.8 per cent and 16.3 per cent stake in each line of patient care would be. Lamictal proportion of patients in the first-line therapy is used mostly psychiatrists' belief that the therapy is effective in patients with bipolar depression.
source : Decision Resources
Translate to : by
SCRIPT IKLAN GANYA DISINIIIIIII
uklik uklik
0 comments:
Post a Comment